Improving Access to Lung Cancer Clinical Trials
Launched by OXFORD BROOKES UNIVERSITY · Mar 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Improving Access to Lung Cancer Clinical Trials," is focused on understanding why only a small number of lung cancer patients in the UK are participating in clinical trials. Clinical trials are research studies that test new treatments, which can provide patients with more options and potentially improve their quality of life. The trial aims to develop a helpful tool for lung cancer nurses to better communicate with their patients about these trials, making it easier for patients to consider participation.
To be part of this trial, nurses must be registered and actively involved in caring for lung cancer patients at one of the six participating NHS hospitals. The study will involve discussions with patients and nurses to identify barriers to trial participation, and then test a new tool designed to improve conversations about clinical trials. Nurses will be asked to share their experiences and provide feedback on the tool, helping to enhance patient engagement in clinical research. Overall, this study seeks to improve access to potentially life-saving treatments for lung cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Registered nurse with Nursing and Midwifery Council
- • Actively involved in the clinical care pathways of lung cancer patients
- • Working at one of the six participating NHS trusts
- • Age between 18-65 years of age
- Exclusion Criteria:
- • Not actively involved in frontline clinical care
- • Not involved in caring for lung cancer patients for at least 30% of their role
- • Employed as a lung cancer research delivery nurse
About Oxford Brookes University
Oxford Brookes University is a leading UK institution known for its commitment to innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, the university actively engages in various clinical trials aimed at advancing healthcare and improving patient outcomes. Leveraging its research expertise and state-of-the-art facilities, Oxford Brookes University fosters a dynamic environment for the development of novel therapies and interventions, contributing to the broader scientific community while prioritizing ethical standards and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, Oxfordshire, United Kingdom
Patients applied
Trial Officials
Catherine L Henshall, PhD
Principal Investigator
Oxford Brookes University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials